| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 10 | 2020 | 83 | 4.830 |
Why?
|
| Vascular Surgical Procedures | 17 | 2022 | 168 | 3.630 |
Why?
|
| Endovascular Procedures | 11 | 2020 | 366 | 3.450 |
Why?
|
| Endarterectomy, Carotid | 9 | 2017 | 110 | 2.690 |
Why?
|
| Decision Support Techniques | 7 | 2020 | 191 | 2.290 |
Why?
|
| Ischemia | 11 | 2019 | 229 | 2.190 |
Why?
|
| Carotid Stenosis | 8 | 2017 | 163 | 2.160 |
Why?
|
| Lower Extremity | 6 | 2022 | 153 | 1.870 |
Why?
|
| Popliteal Artery | 5 | 2020 | 40 | 1.440 |
Why?
|
| Vascular Grafting | 2 | 2019 | 12 | 1.370 |
Why?
|
| Blood Vessel Prosthesis Implantation | 8 | 2020 | 186 | 1.080 |
Why?
|
| Blood Vessel Prosthesis | 13 | 2009 | 182 | 1.030 |
Why?
|
| Intermittent Claudication | 3 | 2022 | 31 | 0.950 |
Why?
|
| General Surgery | 4 | 2014 | 95 | 0.950 |
Why?
|
| Aortic Aneurysm, Abdominal | 9 | 2019 | 139 | 0.920 |
Why?
|
| Risk Factors | 23 | 2020 | 5719 | 0.920 |
Why?
|
| Time Factors | 19 | 2020 | 4655 | 0.910 |
Why?
|
| Renal Dialysis | 3 | 2018 | 174 | 0.840 |
Why?
|
| Leg | 11 | 2004 | 191 | 0.840 |
Why?
|
| Retrospective Studies | 28 | 2020 | 7264 | 0.790 |
Why?
|
| Aged | 49 | 2020 | 14842 | 0.770 |
Why?
|
| Treatment Outcome | 26 | 2020 | 7028 | 0.770 |
Why?
|
| Markov Chains | 5 | 2020 | 133 | 0.750 |
Why?
|
| Limb Salvage | 6 | 2019 | 39 | 0.750 |
Why?
|
| Vena Cava Filters | 1 | 2020 | 18 | 0.740 |
Why?
|
| Foreign-Body Migration | 1 | 2020 | 38 | 0.740 |
Why?
|
| Registries | 8 | 2020 | 730 | 0.690 |
Why?
|
| Device Removal | 1 | 2020 | 100 | 0.690 |
Why?
|
| Quality of Life | 5 | 2020 | 1515 | 0.690 |
Why?
|
| Chi-Square Distribution | 9 | 2018 | 546 | 0.690 |
Why?
|
| Risk Assessment | 11 | 2020 | 2004 | 0.680 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2007 | 50 | 0.670 |
Why?
|
| Statistics as Topic | 1 | 2019 | 219 | 0.670 |
Why?
|
| Internship and Residency | 4 | 2014 | 596 | 0.670 |
Why?
|
| Peritoneal Dialysis | 1 | 2018 | 30 | 0.670 |
Why?
|
| Vascular Patency | 14 | 2020 | 122 | 0.640 |
Why?
|
| Male | 58 | 2020 | 37281 | 0.630 |
Why?
|
| Psoas Muscles | 1 | 2017 | 2 | 0.630 |
Why?
|
| Sarcopenia | 1 | 2017 | 9 | 0.620 |
Why?
|
| Humans | 74 | 2022 | 68525 | 0.620 |
Why?
|
| Female | 56 | 2020 | 38015 | 0.620 |
Why?
|
| Arterial Occlusive Diseases | 5 | 2000 | 134 | 0.600 |
Why?
|
| Health Care Costs | 1 | 2020 | 346 | 0.600 |
Why?
|
| Middle Aged | 44 | 2020 | 21119 | 0.590 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2015 | 21 | 0.590 |
Why?
|
| Lumbar Vertebrae | 1 | 2017 | 112 | 0.580 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 365 | 0.570 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 82 | 0.550 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 136 | 0.550 |
Why?
|
| Aorta, Abdominal | 5 | 2011 | 97 | 0.540 |
Why?
|
| Polytetrafluoroethylene | 8 | 2009 | 55 | 0.530 |
Why?
|
| Aorta, Thoracic | 3 | 2019 | 211 | 0.520 |
Why?
|
| Research Design | 1 | 2019 | 729 | 0.510 |
Why?
|
| Predictive Value of Tests | 7 | 2019 | 1465 | 0.510 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 44 | 0.510 |
Why?
|
| Smoking | 5 | 2018 | 1449 | 0.510 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 177 | 0.490 |
Why?
|
| Aged, 80 and over | 21 | 2020 | 4843 | 0.490 |
Why?
|
| Patients | 1 | 2014 | 69 | 0.490 |
Why?
|
| Surgeons | 1 | 2014 | 68 | 0.470 |
Why?
|
| Patient Compliance | 2 | 2020 | 402 | 0.450 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 424 | 0.450 |
Why?
|
| Femoral Artery | 6 | 2022 | 139 | 0.450 |
Why?
|
| Quality Improvement | 1 | 2017 | 413 | 0.440 |
Why?
|
| Decision Trees | 4 | 2020 | 74 | 0.430 |
Why?
|
| Aortic Aneurysm | 2 | 2011 | 77 | 0.420 |
Why?
|
| Clinical Competence | 2 | 2014 | 657 | 0.420 |
Why?
|
| Stents | 4 | 2014 | 657 | 0.410 |
Why?
|
| Polyethylene Terephthalates | 5 | 1997 | 29 | 0.410 |
Why?
|
| Embolization, Therapeutic | 2 | 2020 | 150 | 0.400 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 1046 | 0.400 |
Why?
|
| Vascular Diseases | 3 | 2015 | 94 | 0.390 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 349 | 0.390 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 839 | 0.380 |
Why?
|
| Logistic Models | 5 | 2018 | 1419 | 0.370 |
Why?
|
| Angioplasty | 4 | 2014 | 118 | 0.360 |
Why?
|
| Aortic Diseases | 3 | 2019 | 113 | 0.360 |
Why?
|
| Societies, Medical | 3 | 2015 | 403 | 0.360 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 70 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 766 | 0.330 |
Why?
|
| Odds Ratio | 5 | 2017 | 880 | 0.320 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 791 | 0.320 |
Why?
|
| School Admission Criteria | 1 | 2007 | 36 | 0.310 |
Why?
|
| Postoperative Complications | 10 | 2019 | 1615 | 0.300 |
Why?
|
| Receptors, Thromboxane | 2 | 1998 | 122 | 0.300 |
Why?
|
| Arteriosclerosis | 2 | 1998 | 137 | 0.300 |
Why?
|
| Graft Occlusion, Vascular | 5 | 1998 | 73 | 0.300 |
Why?
|
| Faculty, Medical | 1 | 2007 | 110 | 0.290 |
Why?
|
| Interviews as Topic | 1 | 2007 | 392 | 0.290 |
Why?
|
| beta-Glucans | 1 | 2006 | 18 | 0.280 |
Why?
|
| Iliac Artery | 4 | 1998 | 44 | 0.280 |
Why?
|
| Arteries | 3 | 2020 | 108 | 0.280 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 536 | 0.270 |
Why?
|
| Linear Models | 2 | 2017 | 521 | 0.250 |
Why?
|
| Premedication | 1 | 2004 | 49 | 0.250 |
Why?
|
| Thoracic Surgery | 1 | 2005 | 72 | 0.240 |
Why?
|
| Smoking Prevention | 2 | 2016 | 259 | 0.240 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 129 | 0.240 |
Why?
|
| Patient Selection | 3 | 2016 | 592 | 0.230 |
Why?
|
| Perioperative Care | 1 | 2004 | 100 | 0.230 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 189 | 0.230 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 172 | 0.230 |
Why?
|
| Spinal Cord Ischemia | 2 | 2020 | 21 | 0.230 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2020 | 105 | 0.220 |
Why?
|
| South Carolina | 7 | 2015 | 2750 | 0.220 |
Why?
|
| Periodicals as Topic | 1 | 2005 | 158 | 0.220 |
Why?
|
| Tibial Arteries | 1 | 2002 | 6 | 0.210 |
Why?
|
| Receptors, Endothelin | 1 | 2002 | 30 | 0.210 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2020 | 20 | 0.210 |
Why?
|
| Databases, Factual | 3 | 2020 | 621 | 0.210 |
Why?
|
| Postoperative Period | 5 | 2009 | 238 | 0.200 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2077 | 0.200 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 378 | 0.200 |
Why?
|
| Prosthesis Design | 2 | 2020 | 301 | 0.200 |
Why?
|
| Anastomosis, Surgical | 6 | 2001 | 104 | 0.190 |
Why?
|
| Comorbidity | 3 | 2018 | 1425 | 0.190 |
Why?
|
| Celiac Artery | 1 | 2020 | 12 | 0.190 |
Why?
|
| Mesenteric Ischemia | 1 | 2020 | 8 | 0.180 |
Why?
|
| Models, Economic | 1 | 2020 | 69 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2020 | 3702 | 0.180 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 12 | 0.180 |
Why?
|
| Cost Savings | 1 | 2020 | 110 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 38 | 0.180 |
Why?
|
| Renal Artery Obstruction | 1 | 1998 | 29 | 0.170 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 15 | 0.170 |
Why?
|
| Carotid Arteries | 3 | 1997 | 110 | 0.170 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 193 | 0.170 |
Why?
|
| Coronary Artery Bypass | 2 | 2011 | 218 | 0.170 |
Why?
|
| Fasciitis | 1 | 1998 | 30 | 0.170 |
Why?
|
| Smoking Cessation | 3 | 2018 | 1032 | 0.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2020 | 134 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2002 | 529 | 0.160 |
Why?
|
| Seat Belts | 1 | 1998 | 12 | 0.160 |
Why?
|
| Thromboembolism | 2 | 1998 | 91 | 0.160 |
Why?
|
| Thrombosis | 2 | 1998 | 218 | 0.160 |
Why?
|
| Life Tables | 5 | 2005 | 29 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 1998 | 25 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 503 | 0.160 |
Why?
|
| Receptors, Prostaglandin | 1 | 1998 | 74 | 0.160 |
Why?
|
| Aspirin | 3 | 1997 | 295 | 0.160 |
Why?
|
| Wound Healing | 1 | 2020 | 260 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 1851 | 0.160 |
Why?
|
| Abdominal Injuries | 1 | 1998 | 60 | 0.150 |
Why?
|
| Frail Elderly | 1 | 2017 | 31 | 0.150 |
Why?
|
| Diabetic Angiopathies | 1 | 1999 | 203 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2020 | 294 | 0.150 |
Why?
|
| Oxazoles | 1 | 1997 | 17 | 0.150 |
Why?
|
| Arthroplasty | 1 | 1997 | 24 | 0.150 |
Why?
|
| Stroke | 5 | 2017 | 2161 | 0.150 |
Why?
|
| Total Quality Management | 1 | 1997 | 45 | 0.150 |
Why?
|
| Thrombophlebitis | 1 | 1997 | 47 | 0.150 |
Why?
|
| Hospital Charges | 1 | 1997 | 60 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2015 | 181 | 0.150 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 107 | 0.150 |
Why?
|
| United States | 4 | 2018 | 7335 | 0.150 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 1997 | 64 | 0.150 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1998 | 131 | 0.150 |
Why?
|
| Blood Platelets | 1 | 1998 | 284 | 0.150 |
Why?
|
| Decision Making | 1 | 2020 | 410 | 0.140 |
Why?
|
| Treatment Failure | 1 | 2016 | 216 | 0.140 |
Why?
|
| Swine | 4 | 2006 | 672 | 0.130 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2011 | 31 | 0.130 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1995 | 22 | 0.130 |
Why?
|
| Hypertension, Renovascular | 1 | 1995 | 47 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2017 | 384 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 48 | 0.130 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 168 | 0.130 |
Why?
|
| Myocardial Infarction | 3 | 2015 | 807 | 0.130 |
Why?
|
| Age Factors | 3 | 2017 | 1860 | 0.130 |
Why?
|
| Software | 1 | 2017 | 418 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 373 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 172 | 0.130 |
Why?
|
| Embolic Protection Devices | 1 | 2014 | 12 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1997 | 373 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 133 | 0.120 |
Why?
|
| Blood Coagulation | 2 | 1995 | 123 | 0.120 |
Why?
|
| Adult | 15 | 2020 | 21375 | 0.120 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 85 | 0.120 |
Why?
|
| Thrombelastography | 1 | 1993 | 19 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2000 | 1447 | 0.120 |
Why?
|
| Coronary Artery Disease | 2 | 2011 | 696 | 0.120 |
Why?
|
| Prognosis | 8 | 2004 | 2093 | 0.120 |
Why?
|
| Coronary Disease | 1 | 2015 | 358 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 142 | 0.110 |
Why?
|
| Hospitalization | 1 | 2019 | 977 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 2323 | 0.110 |
Why?
|
| Varicose Ulcer | 1 | 1993 | 42 | 0.110 |
Why?
|
| Up-Regulation | 1 | 1995 | 682 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2014 | 383 | 0.110 |
Why?
|
| Cefazolin | 1 | 1991 | 19 | 0.100 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2011 | 64 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 705 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 442 | 0.100 |
Why?
|
| Disease Progression | 1 | 2014 | 1037 | 0.100 |
Why?
|
| Workload | 1 | 2011 | 103 | 0.100 |
Why?
|
| Angioplasty, Balloon | 4 | 2020 | 110 | 0.100 |
Why?
|
| Polyurethanes | 1 | 1990 | 21 | 0.090 |
Why?
|
| Hemorrhage | 2 | 1991 | 328 | 0.090 |
Why?
|
| Survival Rate | 3 | 2019 | 1055 | 0.090 |
Why?
|
| Aortic Rupture | 2 | 2008 | 32 | 0.090 |
Why?
|
| Hyperparathyroidism | 2 | 1987 | 40 | 0.090 |
Why?
|
| Hypertension | 2 | 2015 | 1531 | 0.090 |
Why?
|
| Saphenous Vein | 3 | 2006 | 61 | 0.090 |
Why?
|
| Algorithms | 1 | 2015 | 1194 | 0.090 |
Why?
|
| Inguinal Canal | 1 | 2009 | 5 | 0.090 |
Why?
|
| Documentation | 1 | 2010 | 83 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1998 | 2222 | 0.090 |
Why?
|
| Angiography | 3 | 2006 | 194 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 3256 | 0.080 |
Why?
|
| Recurrence | 3 | 2005 | 948 | 0.080 |
Why?
|
| Complement Activation | 2 | 1991 | 145 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 1990 | 247 | 0.080 |
Why?
|
| Parathyroid Glands | 2 | 1987 | 22 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 178 | 0.080 |
Why?
|
| Animals | 12 | 2006 | 20877 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2003 | 1039 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 1988 | 89 | 0.080 |
Why?
|
| Professional Competence | 1 | 2007 | 100 | 0.070 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 25 | 0.070 |
Why?
|
| Locomotion | 1 | 2007 | 135 | 0.070 |
Why?
|
| Aortitis | 1 | 2006 | 5 | 0.070 |
Why?
|
| Clostridium septicum | 1 | 2006 | 5 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2005 | 1548 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2004 | 710 | 0.070 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2014 | 63 | 0.070 |
Why?
|
| Reoperation | 2 | 2019 | 467 | 0.070 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 49 | 0.070 |
Why?
|
| Heart Failure | 1 | 2015 | 1179 | 0.070 |
Why?
|
| Educational Measurement | 1 | 2007 | 254 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2006 | 52 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2004 | 258 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2005 | 126 | 0.060 |
Why?
|
| Length of Stay | 2 | 2019 | 780 | 0.060 |
Why?
|
| Veins | 3 | 2011 | 68 | 0.060 |
Why?
|
| Endothelium, Vascular | 4 | 1991 | 371 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2005 | 248 | 0.060 |
Why?
|
| Blood Vessels | 2 | 1999 | 102 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2004 | 108 | 0.060 |
Why?
|
| Academic Medical Centers | 3 | 2011 | 281 | 0.060 |
Why?
|
| Protamines | 2 | 1995 | 14 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 299 | 0.060 |
Why?
|
| Culture Techniques | 2 | 2002 | 65 | 0.060 |
Why?
|
| Dogs | 5 | 1991 | 490 | 0.060 |
Why?
|
| Endarterectomy | 2 | 1995 | 22 | 0.060 |
Why?
|
| Skin Temperature | 1 | 2003 | 24 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2004 | 1533 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 369 | 0.060 |
Why?
|
| Endoscopy | 1 | 2006 | 464 | 0.060 |
Why?
|
| Venous Insufficiency | 1 | 2003 | 27 | 0.050 |
Why?
|
| Chronic Disease | 4 | 2003 | 1329 | 0.050 |
Why?
|
| Receptor, Endothelin B | 1 | 2002 | 34 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 244 | 0.050 |
Why?
|
| Atherectomy | 1 | 2020 | 7 | 0.050 |
Why?
|
| Coronary Restenosis | 1 | 2020 | 42 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2020 | 11 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2002 | 447 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2000 | 34 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2022 | 183 | 0.050 |
Why?
|
| Aneurysm | 2 | 1998 | 53 | 0.050 |
Why?
|
| Punctures | 1 | 2020 | 35 | 0.050 |
Why?
|
| Ankle | 1 | 2000 | 45 | 0.050 |
Why?
|
| Emergencies | 1 | 2020 | 107 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2000 | 149 | 0.040 |
Why?
|
| Rabbits | 2 | 1991 | 509 | 0.040 |
Why?
|
| ROC Curve | 1 | 2000 | 392 | 0.040 |
Why?
|
| Adolescent | 3 | 1997 | 8903 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2550 | 0.040 |
Why?
|
| Complement System Proteins | 2 | 1991 | 135 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1998 | 41 | 0.040 |
Why?
|
| Prostaglandins H | 1 | 1998 | 32 | 0.040 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 1998 | 48 | 0.040 |
Why?
|
| Cholecystitis | 1 | 1998 | 12 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 1998 | 127 | 0.040 |
Why?
|
| Gangrene | 2 | 1995 | 11 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 1174 | 0.040 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1998 | 59 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 508 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1753 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 2356 | 0.040 |
Why?
|
| Ricin | 1 | 1996 | 6 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 1998 | 109 | 0.040 |
Why?
|
| Critical Pathways | 1 | 1997 | 33 | 0.040 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 1996 | 7 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1997 | 59 | 0.040 |
Why?
|
| Lectins | 1 | 1996 | 81 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 166 | 0.040 |
Why?
|
| Case Management | 1 | 1997 | 46 | 0.040 |
Why?
|
| Heart Arrest, Induced | 1 | 1996 | 52 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 130 | 0.040 |
Why?
|
| Hyperplasia | 3 | 1991 | 89 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1582 | 0.030 |
Why?
|
| Replantation | 1 | 1995 | 8 | 0.030 |
Why?
|
| APACHE | 1 | 1995 | 41 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 1139 | 0.030 |
Why?
|
| Population Surveillance | 1 | 1997 | 285 | 0.030 |
Why?
|
| Sex Factors | 1 | 1999 | 1265 | 0.030 |
Why?
|
| Amaurosis Fugax | 1 | 2014 | 2 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 43 | 0.030 |
Why?
|
| Foot | 1 | 1995 | 66 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 57 | 0.030 |
Why?
|
| Creatinine | 1 | 1995 | 243 | 0.030 |
Why?
|
| Child | 2 | 1996 | 6400 | 0.030 |
Why?
|
| Cause of Death | 1 | 1995 | 241 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 1993 | 57 | 0.030 |
Why?
|
| Bandages, Hydrocolloid | 1 | 1993 | 3 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 167 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1993 | 75 | 0.030 |
Why?
|
| Colloids | 1 | 1993 | 43 | 0.030 |
Why?
|
| Zinc Oxide | 1 | 1993 | 18 | 0.030 |
Why?
|
| Glycerol | 1 | 1993 | 26 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 1745 | 0.030 |
Why?
|
| Epoprostenol | 2 | 1989 | 71 | 0.030 |
Why?
|
| Catheterization | 2 | 1991 | 209 | 0.030 |
Why?
|
| Thrombectomy | 1 | 1995 | 238 | 0.030 |
Why?
|
| Ultrasonography | 1 | 1994 | 453 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 25 | 0.030 |
Why?
|
| Heparin Antagonists | 1 | 1991 | 2 | 0.030 |
Why?
|
| Half-Life | 1 | 1991 | 96 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1991 | 134 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2011 | 169 | 0.020 |
Why?
|
| Resuscitation | 1 | 1991 | 77 | 0.020 |
Why?
|
| Propensity Score | 1 | 2011 | 116 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2011 | 145 | 0.020 |
Why?
|
| Benzofurans | 1 | 1989 | 21 | 0.020 |
Why?
|
| Thromboxane-A Synthase | 1 | 1989 | 24 | 0.020 |
Why?
|
| Thromboxane A2 | 1 | 1989 | 88 | 0.020 |
Why?
|
| Infant | 1 | 1996 | 2891 | 0.020 |
Why?
|
| Materials Testing | 1 | 1990 | 263 | 0.020 |
Why?
|
| Zymosan | 1 | 1988 | 12 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1996 | 3185 | 0.020 |
Why?
|
| Aorta | 1 | 1990 | 316 | 0.020 |
Why?
|
| Sex Chromosomes | 1 | 1988 | 4 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2004 | 714 | 0.020 |
Why?
|
| Constriction | 1 | 1988 | 37 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1988 | 94 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 240 | 0.020 |
Why?
|
| Platelet Count | 1 | 1988 | 100 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 1991 | 419 | 0.020 |
Why?
|
| Anticoagulants | 1 | 1991 | 356 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 284 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1988 | 22 | 0.020 |
Why?
|
| Subclavian Vein | 1 | 1988 | 17 | 0.020 |
Why?
|
| Michigan | 1 | 1988 | 68 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 1988 | 39 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 1988 | 72 | 0.020 |
Why?
|
| Drug Therapy | 1 | 1988 | 71 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2010 | 502 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1987 | 36 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1989 | 317 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1987 | 36 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1988 | 205 | 0.020 |
Why?
|
| Aneurysm, Infected | 1 | 2006 | 16 | 0.020 |
Why?
|
| Colonoscopy | 1 | 1987 | 156 | 0.020 |
Why?
|
| Colectomy | 1 | 2006 | 64 | 0.020 |
Why?
|
| Aneurysm, False | 1 | 2006 | 60 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 772 | 0.020 |
Why?
|
| Risk | 1 | 1987 | 563 | 0.020 |
Why?
|
| Axilla | 1 | 2004 | 36 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 76 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2004 | 91 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 191 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 579 | 0.010 |
Why?
|
| Thermography | 1 | 2003 | 20 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 80 | 0.010 |
Why?
|
| Leg Ulcer | 1 | 2003 | 26 | 0.010 |
Why?
|
| Nursing Assessment | 1 | 2003 | 70 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 799 | 0.010 |
Why?
|
| Computer Systems | 1 | 2001 | 42 | 0.010 |
Why?
|
| Reference Standards | 1 | 2001 | 115 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 251 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 302 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2001 | 274 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 306 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 1015 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1991 | 250 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 1446 | 0.010 |
Why?
|
| Cholangiography | 1 | 1998 | 55 | 0.010 |
Why?
|
| Polyesters | 1 | 1998 | 55 | 0.010 |
Why?
|
| Aortography | 1 | 1998 | 72 | 0.010 |
Why?
|
| Sphincter of Oddi | 1 | 1998 | 51 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1998 | 69 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1986 | 1085 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 1996 | 13 | 0.010 |
Why?
|
| Picolines | 1 | 1996 | 8 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 1663 | 0.010 |
Why?
|
| Pyrans | 1 | 1996 | 16 | 0.010 |
Why?
|
| Immunotoxins | 1 | 1996 | 23 | 0.010 |
Why?
|
| Manometry | 1 | 1998 | 276 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1996 | 55 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 204 | 0.010 |
Why?
|
| Adenosine | 1 | 1996 | 165 | 0.010 |
Why?
|
| Hematocrit | 1 | 1995 | 70 | 0.010 |
Why?
|
| Hemostasis | 1 | 1995 | 32 | 0.010 |
Why?
|
| Obesity | 1 | 2003 | 1074 | 0.010 |
Why?
|
| Graft Survival | 1 | 1998 | 465 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 314 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 631 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1996 | 383 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1995 | 79 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 742 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 348 | 0.010 |
Why?
|
| Heparin | 1 | 1995 | 205 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1995 | 249 | 0.010 |
Why?
|
| Complement C3b | 1 | 1991 | 3 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1995 | 1737 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1991 | 133 | 0.010 |
Why?
|
| Pain | 1 | 1995 | 472 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1991 | 144 | 0.010 |
Why?
|
| Complement C3 | 1 | 1991 | 101 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1991 | 130 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 1990 | 29 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1996 | 2790 | 0.010 |
Why?
|
| Apoptosis | 1 | 1996 | 1640 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 693 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1991 | 249 | 0.010 |
Why?
|
| Karyotyping | 1 | 1988 | 74 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1991 | 313 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1988 | 122 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1991 | 705 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1988 | 242 | 0.000 |
Why?
|
| Sigmoidoscopy | 1 | 1987 | 38 | 0.000 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1986 | 6 | 0.000 |
Why?
|
| Colon | 1 | 1987 | 168 | 0.000 |
Why?
|
| Mice | 1 | 1996 | 8472 | 0.000 |
Why?
|
| Insulin | 1 | 1986 | 617 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1986 | 631 | 0.000 |
Why?
|